Our mission is to bring together the best minds in business, science, medicine, research, finance, and agriculture to create a global platform for the reintroduction of cannabis-based therapeutics into the mainstream of healthcare.
We research, produce, and partner to distribute products around the globe that are designed to target and treat seven major categories of medical conditions: pain, cancer, autoimmune, metabolic, neurological, psychological, and sleep disorders. Creating a patient-centric alternative to the low efficacy and the high side effects of conventional pharmaceuticals, including opiate based painkillers, TNF-inhibitors, anti-inflammatories, biologic medications, antidepressants, and sleep medications.
Phoenix has plans to open production facilities in locations that have legalized medical marijuana programs. By complying with state specific medical cannabis legislation, Phoenix will be able to provide full spectrum products within the borders of those specific states, and for the first time allow a true interface between the doctor/patient/dispensary relationships.